Jacinto Medical Corporation is categorized under Test Development and Evaluation Services in Baytown, TX and active since 1992.
Jacinto Medical Corporation was established in 1992, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Test Development and Evaluation Services business, which does work in the B2B market, and is classified as a Test Development and Evaluation Services, under code number 611710 by the NAICS.
If you are seeking more information, feel free to contact Stephanie Schwartz at the company’s single location by writing to 2800 Garth Road # Q, Baytown, Texas TX 77521 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Jacinto Medical Corporation |
| Contact Person: | Stephanie Schwartz |
| Address: | 2800 Garth Road # Q, Baytown, Texas 77521 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1992 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Test Development and Evaluation Services |
| SIC Code: | 8748 |
| NAICS Code: | 611710 |
| Share This Business: |
Jacinto Medical Corporation was started in 1992 to provide professional Test Development and Evaluation Services under the SIC code 8748 and NAICS code 611710. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Stephanie Schwartz for inquiries that concern Jacinto Medical Corporation by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Jacinto Medical Corporation can be found at the coordinates as well as the street address 2800 Garth Road # Q in Baytown, Texas 77521.
For its online presence, you may visit Jacinto Medical Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.